Amferia
Gothenburg, SE · 2 known investors
Find your way into Amferia
880 people in our graph share verified history with the Amferia team — schools, employers, funds. One of them is your warm intro.
Deep Nisharunlockedknows Saba Atefyekta · together at Stanford University (overlapped)
×8knows the team · via Stanford University
×3knows the team · via Chalmers University of Technology
Amferia develops antimicrobial hydrogel wound dressings that kill bacteria including antibiotic-resistant strains using peptides bonded to hydrogel, for human and veterinary wound care applications. The company's patented technology creates a new class of medical device approved by the FDA for advanced wound management.
Founders & leadership
AK
Anand Kumar RajasekharaninPhD, CEO & Co-founderAnand Kumar Rajasekharan holds a PhD in Materials Science from Chalmers University, Sweden, and is CEO and co-founder of Amferia, which develops antimicrobial hydrogel wound dressings for advanced wound management.
SA
Saba AtefyektainPhD, Sales & Marketing Director & Co-founderSaba Atefyekta holds a PhD and co-founded Amferia, which develops antimicrobial hydrogel wound dressings using peptide technology to treat bacterial infections, including antibiotic-resistant strains, for human and veterinary applications.
MA
Martin AnderssonPhD, R&D Director & Co-founder
Investors · 2
In the news
Frequently asked questions
- What does Amferia do?
- Amferia develops antimicrobial hydrogel wound dressings that kill bacteria including antibiotic-resistant strains using peptides bonded to hydrogel, for human and veterinary wound care applications. The company's patented technology creates a new class of medical device approved by the FDA for advanced wound management.
- Who founded Amferia?
- Amferia was founded by Anand Kumar Rajasekharan, Saba Atefyekta, Martin Andersson.
- Who are Amferia's investors?
- Amferia's investors include Chalmers Ventures AB, Almi Invest.
- Where is Amferia headquartered?
- Amferia is headquartered in Gothenburg, SE.